Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf [Yahoo! Finance]
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: Yahoo! Finance
TD Cowen's 46th Annual Health Care Conference, emphasizing expected inflection points in 2026 tied to its ECO Synthesis platform and continued execution in its legacy pharma biocatalysis business. Shift in emphasis toward RNA medicines manufacturing Moore described Codexis as a company that “generates manufacturing solutions using its proprietary biocatalytic enzymes,” noting it has supplied customized enzymes to pharmaceutical manufacturing customers for years. She said the company's evolution is a sharpened focus on RNA medicines, where Codexis sees a need for innovative manufacturing technologies and has been investing effort for the last three to four years. ? Costco Wholesale: Buy Now, Get Paid Later as Cash and Returns Build Looking toward 2026, Moore said Codexis expects some existing customers to move into “more significant contracts” related to its ECO Synthesis manufacturing platform. She also pointed to what the company views as an opportunity for the products gener
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- Codexis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform [Seeking Alpha]Seeking Alpha
- Codexis (CDXS) was given a new $5.00 price target by Stifel Nicolaus.MarketBeat
- Codexis (CDXS) had its "overweight" rating reaffirmed by Cantor Fitzgerald.MarketBeat
CDXS
Earnings
- 3/11/26 - Beat
CDXS
Analyst Actions
- 3/12/26 - Cantor Fitzgerald
CDXS
Sec Filings
- 3/11/26 - Form 10-K
- 3/11/26 - Form 8-K
- 3/11/26 - Form SCHEDULE
- CDXS's page on the SEC website